90 related articles for article (PubMed ID: 29431550)
1. In silico analysis of anti-leukemia immune response and immune evasion in acute myeloid leukemia.
Krupar R; Schreiber C; Offermann A; Lengerke C; Sikora AG; Thorns C; Perner S
Leuk Lymphoma; 2018 Oct; 59(10):2493-2496. PubMed ID: 29431550
[No Abstract] [Full Text] [Related]
2. An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving Chemotherapy.
Wang Y; Cai YY; Herold T; Nie RC; Zhang Y; Gale RP; Metzeler KH; Zeng Y; Wang SQ; Pan XY; Yang TH; Wu YB; Zhang Q; Wuxiao ZJ; Du X; Liang ZW; Su YZ; Xu JB; Wang YQ; Liu ZL; Wu JW; Zhang X; Wu BY; Xiao RZ; Wang SB; Li JY; Chi PD; Zhang QY; Chen SL; Qin ZY; Zhang XM; Zhong N; Hiddemann W; Liu QF; Zhang B; Liang Y
Clin Cancer Res; 2021 Jan; 27(1):255-266. PubMed ID: 33262139
[TBL] [Abstract][Full Text] [Related]
3. Cortisol facilitates the immune escape of human acute myeloid leukemia cells by inducing latrophilin 1 expression.
Sakhnevych SS; Yasinska IM; Bratt AM; Benlaouer O; Gonçalves Silva I; Hussain R; Siligardi G; Fiedler W; Wellbrock J; Gibbs BF; Ushkaryov YA; Sumbayev VV
Cell Mol Immunol; 2018 Nov; 15(11):994-997. PubMed ID: 29907881
[No Abstract] [Full Text] [Related]
4. Complex Immune Evasion Strategies in Classical Hodgkin Lymphoma.
Wein F; Weniger MA; Höing B; Arnolds J; Hüttmann A; Hansmann ML; Hartmann S; Küppers R
Cancer Immunol Res; 2017 Dec; 5(12):1122-1132. PubMed ID: 29070649
[TBL] [Abstract][Full Text] [Related]
5. Contribution of CD39 to the immunosuppressive microenvironment of acute myeloid leukaemia at diagnosis.
Dulphy N; Henry G; Hemon P; Khaznadar Z; Dombret H; Boissel N; Bensussan A; Toubert A
Br J Haematol; 2014 Jun; 165(5):722-5. PubMed ID: 24666252
[No Abstract] [Full Text] [Related]
6. Characteristics of NK cells from leukemic microenvironment in MLL-AF9 induced acute myeloid leukemia.
Yang F; Wang R; Feng W; Chen C; Yang X; Wang L; Hu Y; Ren Q; Zheng G
Mol Immunol; 2018 Jan; 93():68-78. PubMed ID: 29154208
[TBL] [Abstract][Full Text] [Related]
7. The immunophenotype of acute myeloid leukemia: is there a relationship with prognosis?
Mason KD; Juneja SK; Szer J
Blood Rev; 2006 Mar; 20(2):71-82. PubMed ID: 16185796
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and prognosis of acute myeloid leukemia associated with DNA-methylation regulatory gene mutations.
Ryotokuji T; Yamaguchi H; Ueki T; Usuki K; Kurosawa S; Kobayashi Y; Kawata E; Tajika K; Gomi S; Kanda J; Kobayashi A; Omori I; Marumo A; Fujiwara Y; Yui S; Terada K; Fukunaga K; Hirakawa T; Arai K; Kitano T; Kosaka F; Tamai H; Nakayama K; Wakita S; Fukuda T; Inokuchi K
Haematologica; 2016 Sep; 101(9):1074-81. PubMed ID: 27247325
[TBL] [Abstract][Full Text] [Related]
9. The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment.
Isidori A; Salvestrini V; Ciciarello M; Loscocco F; Visani G; Parisi S; Lecciso M; Ocadlikova D; Rossi L; Gabucci E; Clissa C; Curti A
Expert Rev Hematol; 2014 Dec; 7(6):807-18. PubMed ID: 25227702
[TBL] [Abstract][Full Text] [Related]
10. Tumour growth and immune evasion as targets for a new strategy in advanced cancer.
Nicolini A; Ferrari P; Rossi G; Carpi A
Endocr Relat Cancer; 2018 Nov; 25(11):R577–R604. PubMed ID: 30306784
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors.
Damiani D; Tiribelli M; Raspadori D; Sirianni S; Meneghel A; Cavalllin M; Michelutti A; Toffoletti E; Geromin A; Simeone E; Bocchia M; Fanin R
Oncotarget; 2015 Oct; 6(30):30212-21. PubMed ID: 26338961
[TBL] [Abstract][Full Text] [Related]
12. Anti-Tumor and Immune Enhancing Activities of Rice Bran Gramisterol on Acute Myelogenous Leukemia.
Somintara S; Leardkamolkarn V; Suttiarporn P; Mahatheeranont S
PLoS One; 2016; 11(1):e0146869. PubMed ID: 26752299
[TBL] [Abstract][Full Text] [Related]
13. The bone marrow microenvironment is a critical player in the NK cell response against acute myeloid leukaemia in vitro.
Vasold J; Wagner M; Drolle H; Deniffel C; Kütt A; Oostendorp R; Sironi S; Rieger C; Fiegl M
Leuk Res; 2015 Feb; 39(2):257-62. PubMed ID: 25542695
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory Drugs: Immune Checkpoint Agents in Acute Leukemia.
Knaus HA; Kanakry CG; Luznik L; Gojo I
Curr Drug Targets; 2017; 18(3):315-331. PubMed ID: 25981611
[TBL] [Abstract][Full Text] [Related]
15. High-throughput profiling of signaling networks identifies mechanism-based combination therapy to eliminate microenvironmental resistance in acute myeloid leukemia.
Zeng Z; Liu W; Tsao T; Qiu Y; Zhao Y; Samudio I; Sarbassov DD; Kornblau SM; Baggerly KA; Kantarjian HM; Konopleva M; Andreeff M
Haematologica; 2017 Sep; 102(9):1537-1548. PubMed ID: 28659338
[TBL] [Abstract][Full Text] [Related]
16. Low SMC1A protein expression predicts poor survival in acute myeloid leukemia.
Hömme C; Krug U; Tidow N; Schulte B; Kühler G; Serve H; Bürger H; Berdel WE; Dugas M; Heinecke A; Büchner T; Koschmieder S; Müller-Tidow C
Oncol Rep; 2010 Jul; 24(1):47-56. PubMed ID: 20514443
[TBL] [Abstract][Full Text] [Related]
17. Expression of beta-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis.
Ysebaert L; Chicanne G; Demur C; De Toni F; Prade-Houdellier N; Ruidavets JB; Mansat-De Mas V; Rigal-Huguet F; Laurent G; Payrastre B; Manenti S; Racaud-Sultan C
Leukemia; 2006 Jul; 20(7):1211-6. PubMed ID: 16688229
[TBL] [Abstract][Full Text] [Related]
18. Antileukemic T-cell-mediated immune reactions: limitations and perspectives for future therapies.
Schmetzer HM
Immunotherapy; 2011 Jul; 3(7):809-11. PubMed ID: 21751947
[No Abstract] [Full Text] [Related]
19. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.
Shi JL; Fu L; Wang WD
Oncotarget; 2015 Mar; 6(7):5299-309. PubMed ID: 25779662
[TBL] [Abstract][Full Text] [Related]
20. Lymphoma Microenvironment and Immunotherapy.
Xu ML; Fedoriw Y
Surg Pathol Clin; 2016 Mar; 9(1):93-100. PubMed ID: 26940270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
